Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
64.142,91
0,39%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX Annovis Bio Inc (ANVS) Annovis Bio Inc (ANVS) Notizie

ANVS

Annovis Bio (ANVS)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:ANVS
DataOraFonteTitoloSimboloCompagnia
01/04/202414:00GlobeNewswire Inc.Annovis Announces Publication That Supports Understanding of Buntanetap’s Mechanism of Action in HumansAMEX:ANVSAnnovis Bio Inc
20/03/202412:30GlobeNewswire Inc.Annovis Bio Provides Data Announcement Update for the Phase II/III Study of Buntanetap in Alzheimer’s DiseaseAMEX:ANVSAnnovis Bio Inc
27/02/202414:00GlobeNewswire Inc.Annovis Bio Announces Participation in Forum Discussion at AD/PD™ 2024AMEX:ANVSAnnovis Bio Inc
14/02/202413:30GlobeNewswire Inc.Annovis Bio Announces Last Patient Last Visit in the Phase II/III Study of Buntanetap in Alzheimer’s DiseaseAMEX:ANVSAnnovis Bio Inc
30/01/202414:00GlobeNewswire Inc.Annovis Bio Announces the Filing of New Patent Application for Treatment of Mental Illnesses Expanding the Company’s PortfolioAMEX:ANVSAnnovis Bio Inc
24/01/202414:00GlobeNewswire Inc.Annovis Bio Refines Timeline for Parkinson’s Phase III Study Data AnnouncementAMEX:ANVSAnnovis Bio Inc
11/12/202319:00GlobeNewswire Inc.Annovis Bio to Participate in the 139th Yale CEO SummitAMEX:ANVSAnnovis Bio Inc
05/12/202313:30GlobeNewswire Inc.Annovis Bio Announces Last Patient Last Visit in the Phase III Study of Buntanetap in Parkinson’s DiseaseAMEX:ANVSAnnovis Bio Inc
01/12/202313:30GlobeNewswire Inc.Annovis Bio Appoints Andrew Walsh as Vice President FinanceAMEX:ANVSAnnovis Bio Inc
27/11/202313:30GlobeNewswire Inc.Annovis Bio Announces Full Enrollment of Its Phase II/III Alzheimer’s Disease Trial, Exceeding Original ProjectionsAMEX:ANVSAnnovis Bio Inc
08/11/202323:00GlobeNewswire Inc.Annovis Bio Announces Third Quarter 2023 Financial Results and Provides Corporate UpdateAMEX:ANVSAnnovis Bio Inc
12/10/202314:02GlobeNewswire Inc.Annovis Bio Announces Positive Interim Independent Analysis for Statistical Power in Its Alzheimer’s StudyAMEX:ANVSAnnovis Bio Inc
16/06/202322:19Edgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
10/05/202322:35Edgar (US Regulatory)Quarterly Report (10-q)AMEX:ANVSAnnovis Bio Inc
28/04/202314:01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:ANVSAnnovis Bio Inc
26/04/202322:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
25/04/202312:01Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)AMEX:ANVSAnnovis Bio Inc
18/04/202222:14Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:ANVSAnnovis Bio Inc
02/03/202222:18Edgar (US Regulatory)Annual Report (10-k)AMEX:ANVSAnnovis Bio Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:ANVS

La tua Cronologia

BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
STMMI
ST Microelectronics
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
BIT
ENI
Eni
BIT
RACE
Ferrari NV
BIT
TIT
Telecom Italia
BIT
SPM
Saipem
BIT
SRG
Snam
BIT
TEN
Tenaris
BIT
TRN
Terna Trasmissione Elett...
BIT
IVG
Iveco Group NV
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network